Jean George - Insider Trading Tracker

ALX腫瘤控股公司

US ˙ NasdaqGS ˙ US00166B1052

簡介

本頁面提供了有關 Jean George 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。

報告內部持倉的公司

SEC文件顯示Jean George已報告在以下公司擁有持倉或進行了交易：

證券	職位	最新報告的持倉
		1,885,136
US:CYT / Cyteir Therapeutics, Inc.	Director	14,150
US:ALXO / ALX Oncology Holdings Inc.	10% Owner	285,956
US:CALA / Calithera Biosciences, Inc.	Director	20,000
US:GMTX / Gemini Therapeutics Inc	Director, 10% Owner	2,796,868
US:XLRN / Acceleron Pharma Inc	Director	8,185
US:CATB / Astria Therapeutics Inc	Director	14,000
US:ZLTQ / ZELTIQ Aesthetics, Inc.	Director	5,786
	Director	0

如何解讀這些圖表

以下圖表顯示了在Jean George進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

ALXO / ALX Oncology Holdings Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ALXO / ALX Oncology Holdings Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
2020-07-21	ALXO	LSV Associates, LLC	378,000	19.0000	378,000	19.0000	7,182,000	142	112.26	35,252,280	490.84
2020-07-21	ALXO	LSV Associates, LLC	22,000	19.0000	22,000	19.0000	418,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ALXO / ALX Oncology Holdings Inc. Insider Trades

ALXO / ALX Oncology Holdings Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ALXO / ALX Oncology Holdings Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
2021-12-13	ALXO	LSV Associates, LLC	11,945	25.2900	11,945	25.2900	302,089	185	5.8900	-231,733	-76.71
2021-12-13	ALXO	LSV Associates, LLC	1,627	25.2900	1,627	25.2900	41,147
2021-12-13	ALXO	LSV Associates, LLC	17,169	26.4800	17,169	26.4800	454,635
2021-12-13	ALXO	LSV Associates, LLC	2,339	26.4800	2,339	26.4800	61,937
2021-12-13	ALXO	LSV Associates, LLC	9,509	27.4900	9,509	27.4900	261,402
2021-12-13	ALXO	LSV Associates, LLC	1,296	27.4900	1,296	27.4900	35,627
2021-12-13	ALXO	LSV Associates, LLC	2,196	28.3700	2,196	28.3700	62,301
2021-12-13	ALXO	LSV Associates, LLC	299	28.3700	299	28.3700	8,483
2021-12-13	ALXO	LSV Associates, LLC	1,329	29.6000	1,329	29.6000	39,338
2021-12-13	ALXO	LSV Associates, LLC	181	29.6000	181	29.6000	5,358
2021-12-13	ALXO	LSV Associates, LLC	440	30.2300	440	30.2300	13,301
2021-12-13	ALXO	LSV Associates, LLC	60	30.2300	60	30.2300	1,814
2021-12-10	ALXO	LSV Associates, LLC	7,093	30.7700	7,093	30.7700	218,252
2021-12-10	ALXO	LSV Associates, LLC	967	30.7700	967	30.7700	29,755
2021-12-10	ALXO	LSV Associates, LLC	15,942	31.5500	15,942	31.5500	502,970
2021-12-10	ALXO	LSV Associates, LLC	2,172	31.5500	2,172	31.5500	68,527
2021-12-10	ALXO	LSV Associates, LLC	88	32.1600	88	32.1600	2,830
2021-12-10	ALXO	LSV Associates, LLC	12	32.1600	12	32.1600	386
2021-12-09	ALXO	LSV Associates, LLC	11,452	31.0800	11,452	31.0800	355,928
2021-12-09	ALXO	LSV Associates, LLC	1,560	31.0800	1,560	31.0800	48,485
2021-12-09	ALXO	LSV Associates, LLC	42,203	32.0600	42,203	32.0600	1,353,028
2021-12-09	ALXO	LSV Associates, LLC	5,751	32.0600	5,751	32.0600	184,377
2021-12-09	ALXO	LSV Associates, LLC	14,028	32.7300	14,028	32.7300	459,136
2021-12-09	ALXO	LSV Associates, LLC	1,911	32.7300	1,911	32.7300	62,547
2021-12-08	ALXO	LSV Associates, LLC	35,836	33.2300	35,836	33.2300	1,190,830
2021-12-08	ALXO	LSV Associates, LLC	4,883	33.2300	4,883	33.2300	162,262
2021-12-08	ALXO	LSV Associates, LLC	1,531	33.8000	1,531	33.8000	51,748
2021-12-08	ALXO	LSV Associates, LLC	208	33.8000	208	33.8000	7,030

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CALA / Calithera Biosciences, Inc.內部人士買入 - 短期收益分析

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CALA / Calithera Biosciences, Inc. Insider Trades

CALA / Calithera Biosciences, Inc.內部人士賣出 - 短期虧損分析

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

歷史內部人交易

該表格顯示了由 Jean George 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期	交易日期	表格	證券代碼	證券	代碼	10b5-1	股份	剩餘股份	% 變化	每股股價	交易金額	剩餘金額
2025-08-05	2025-08-01	4	SI	SHOULDER INNOVATIONS, INC. Common Stock	P - Purchase		266,666	1,885,136	16.48	15.00	3,999,990	28,277,040
2025-08-05	2025-08-01	4	SI	SHOULDER INNOVATIONS, INC. Common Stock	C - Conversion		1,618,470	1,618,470
2024-02-16	2024-02-14	4	CYT	Cyteir Therapeutics, Inc. Common Stock	M - Exercise		14,150	14,150		1.69	23,914	23,914
2022-02-24	2022-02-22	4	CYT	Cyteir Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		14,150	14,150
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-60	285,956	-0.02	30.23	-1,814	8,644,450
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-440	2,097,326	-0.02	30.23	-13,301	63,402,165
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-181	286,016	-0.06	29.60	-5,358	8,466,074
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-1,329	2,097,766	-0.06	29.60	-39,338	62,093,874
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-299	286,197	-0.10	28.37	-8,483	8,119,409
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-2,196	2,099,095	-0.10	28.37	-62,301	59,551,325
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-1,296	286,496	-0.45	27.49	-35,627	7,875,775
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-9,509	2,101,291	-0.45	27.49	-261,402	57,764,490
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-2,339	287,792	-0.81	26.48	-61,937	7,620,732
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-17,169	2,110,800	-0.81	26.48	-454,635	55,893,984
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-1,627	290,131	-0.56	25.29	-41,147	7,337,413
2021-12-15	2021-12-13	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-11,945	2,127,969	-0.56	25.29	-302,089	53,816,336
2021-12-10	2021-12-10	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-12	291,758	0.00	32.16	-386	9,382,937
2021-12-10	2021-12-10	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-88	2,139,914	0.00	32.16	-2,830	68,819,634
2021-12-10	2021-12-10	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-2,172	291,770	-0.74	31.55	-68,527	9,205,344
2021-12-10	2021-12-10	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-15,942	2,140,002	-0.74	31.55	-502,970	67,517,063
2021-12-10	2021-12-10	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-967	293,942	-0.33	30.77	-29,755	9,044,595
2021-12-10	2021-12-10	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-7,093	2,155,944	-0.33	30.77	-218,252	66,338,397
2021-12-10	2021-12-09	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-1,911	294,909	-0.64	32.73	-62,547	9,652,372
2021-12-10	2021-12-09	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-14,028	2,163,037	-0.64	32.73	-459,136	70,796,201
2021-12-10	2021-12-09	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-5,751	296,820	-1.90	32.06	-184,377	9,516,049
2021-12-10	2021-12-09	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-42,203	2,177,065	-1.90	32.06	-1,353,028	69,796,704
2021-12-10	2021-12-09	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-1,560	302,571	-0.51	31.08	-48,485	9,403,907
2021-12-10	2021-12-09	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-11,452	2,219,268	-0.51	31.08	-355,928	68,974,849
2021-12-10	2021-12-08	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-208	304,131	-0.07	33.80	-7,030	10,279,628
2021-12-10	2021-12-08	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-1,531	2,230,720	-0.07	33.80	-51,748	75,398,336
2021-12-10	2021-12-08	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-4,883	304,339	-1.58	33.23	-162,262	10,113,185
2021-12-10	2021-12-08	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	S - Sale		-35,836	2,232,251	-1.58	33.23	-1,190,830	74,177,701
2021-06-24	2021-06-22	4	CYT	Cyteir Therapeutics, Inc. Series C Convertible Preferred Stock	C - Conversion		-832,026	0	-100.00
2021-06-24	2021-06-22	4	CYT	Cyteir Therapeutics, Inc. Series B Convertible Preferred Stock	C - Conversion		-7,500,000	0	-100.00
2021-06-24	2021-06-22	4	CYT	Cyteir Therapeutics, Inc. Common Stock	C - Conversion		2,444,268	2,444,268
2021-06-14	2021-06-11	4	CALA	Calithera Biosciences, Inc. Stock Option (Right to Buy)	A - Award		20,000	20,000
2021-02-16		3	GMTX	Gemini Therapeutics, Inc. /DE Common Stock				2,796,868
2021-02-16		3	GMTX	Gemini Therapeutics, Inc. /DE Common Stock				381,040
2021-02-16		3	GMTX	Gemini Therapeutics, Inc. /DE Common Stock				1,658,198
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series C Convertible Preferred Stock	C - Conversion		-38,660	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series C Convertible Preferred Stock	C - Conversion		-664,660	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series C Convertible Preferred Stock	C - Conversion		-18,705	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series C Convertible Preferred Stock	C - Conversion		-137,286	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series B Convertible Preferred Stock	C - Conversion		-11,110	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series B Convertible Preferred Stock	C - Conversion		-150,801	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series B Convertible Preferred Stock	C - Conversion		-8,175	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series B Convertible Preferred Stock	C - Conversion		-59,998	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series A Convertible Preferred Stock	C - Conversion		-39,758	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series A Convertible Preferred Stock	C - Conversion		-683,523	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series A Convertible Preferred Stock	C - Conversion		-222,752	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Series A Convertible Preferred Stock	C - Conversion		-1,633,743	0	-100.00
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	C - Conversion		111,528	120,212	1,284.29
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	P - Purchase		22,000	22,000		19.00	418,000	418,000
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	C - Conversion		1,498,984	2,023,469	285.80
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	P - Purchase		378,000	378,000		19.00	7,182,000	7,182,000
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	C - Conversion		249,632	309,222	418.92
2020-07-22	2020-07-21	4	ALXO	ALX ONCOLOGY HOLDINGS INC Common Stock	C - Conversion		1,831,027	2,268,087	418.94
2020-06-11	2020-06-09	4	CALA	Calithera Biosciences, Inc. Stock Option (Right to Buy)	A - Award		20,000	20,000
2020-01-24	2020-01-22	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		8,185	8,185
2020-01-24	2020-01-22	4	XLRN	ACCELERON PHARMA INC Common Stock	A - Award		1,377	5,127	36.72
2019-06-28	2019-06-28	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-11,812	0	-100.00	41.17	-486,300
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	M - Exercise		-7,500	0	-100.00
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	M - Exercise		-10,000	0	-100.00
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	M - Exercise		-20,000	0	-100.00
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Common Stock	J - Other		11,812	11,812
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Common Stock	J - Other		-11,812	3,750	-75.90
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-25,688	15,562	-62.27	39.16	-1,005,942	609,408
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Common Stock	M - Exercise		7,500	41,250	22.22	30.17	226,275	1,244,512
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Common Stock	M - Exercise		10,000	33,750	42.11	27.97	279,700	943,988
2019-06-28	2019-06-26	4	XLRN	ACCELERON PHARMA INC Common Stock	M - Exercise		20,000	23,750	533.33	24.11	482,200	572,612
2019-06-03	2019-05-30	4	CALA	Calithera Biosciences, Inc. Stock Option (Right to Buy)	A - Award		11,000	11,000
2019-01-29	2019-01-25	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		7,500	7,500
2019-01-29	2019-01-25	4	XLRN	ACCELERON PHARMA INC Common Stock	A - Award		1,250	3,750	50.00
2018-06-07	2018-06-07	4	CATB	CATABASIS PHARMACEUTICALS INC Stock Option (right to buy)	A - Award		14,000	14,000
2018-06-04	2018-05-31	4	CALA	Calithera Biosciences, Inc. Stock Option (Right to Buy)	A - Award		11,000	11,000
2018-03-05	2018-03-01	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		7,500	7,500
2018-03-05	2018-03-01	4	XLRN	ACCELERON PHARMA INC Common Stock	A - Award		1,250	2,500	100.00
2017-12-18	2017-12-15	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-105,122	0	-100.00	35.73	-3,756,009
2017-07-28	2017-07-27	4	CATB	CATABASIS PHARMACEUTICALS INC Stock Option (right to buy)	A - Award		6,500	6,500
2017-06-13	2017-06-09	4	CALA	Calithera Biosciences, Inc. Stock Option (Right to Buy)	A - Award		11,000	11,000
2017-03-14	2017-03-02	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		7,500	7,500
2017-03-14	2017-03-02	4	XLRN	ACCELERON PHARMA INC Common Stock	A - Award		1,250	1,250
2016-12-19	2016-12-07	4	XLRN	ACCELERON PHARMA INC Warrants to Purchase Common Stock	M - Exercise		-127,122	0	-100.00
2016-12-19	2016-12-07	4	XLRN	ACCELERON PHARMA INC Common Stock	F - Taxes		-22,000	105,122	-17.31	33.98	-747,560	3,572,046
2016-12-19	2016-12-07	4	XLRN	ACCELERON PHARMA INC Common Stock	M - Exercise		127,122	127,122		5.88	747,477	747,477
2016-11-18	2016-11-17	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-379,464	0	-100.00	38.05	-14,438,605
2016-11-18	2016-11-17	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-41,112	379,464	-9.78	39.13	-1,608,713	14,848,426
2016-11-18	2016-11-16	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-32,929	420,576	-7.26	41.39	-1,362,931	17,407,641
2016-10-04	2016-09-30	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-857,145	453,505	-65.40	35.50	-30,428,648	16,099,428
2016-08-05	2016-08-03	4	CATB	CATABASIS PHARMACEUTICALS INC Stock Option (right to buy)	A - Award		6,500	6,500
2016-06-16	2016-06-14	4	CALA	Calithera Biosciences, Inc. Stock Option (Right to Buy)	A - Award		11,000	11,000
2016-03-07	2016-03-03	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		10,000	10,000
2015-07-23	2015-07-22	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	A - Award		790	5,786	15.81
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Stock Option (right to buy)	A - Award		11,094	11,094
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-1,006,712	0	-100.00
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-7,388,491	0	-100.00
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-3,910,392	0	-100.00
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Series A Preferred Stock	C - Conversion		-8,666,667	0	-100.00
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Common Stock	P - Purchase		12,422	90,764	15.86	12.00	149,064	1,089,168
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Common Stock	P - Purchase		91,166	666,145	15.86	12.00	1,093,992	7,993,740
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Common Stock	P - Purchase		155,188	1,133,943	15.86	12.00	1,862,256	13,607,316
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Common Stock	C - Conversion		78,342	78,342
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Common Stock	C - Conversion		574,979	574,979
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Common Stock	C - Conversion		304,309	978,755	45.12
2015-06-30	2015-06-30	4	CATB	CATABASIS PHARMACEUTICALS INC Common Stock	C - Conversion		674,446	674,446
2015-06-19	2015-06-17	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	A - Award		4,996	4,996
2015-06-11	2015-06-09	4	CALA	Calithera Biosciences, Inc. Stock Option (Right to Buy)	A - Award		11,000	11,000
2015-04-08	2015-01-08	4/A	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		10,000	10,000
2015-01-16	2015-01-15	4	ZLTQ	Zeltiq Aesthetics Inc Stock Options (Right to Buy)	M - Exercise		-596	3,377	-15.00
2015-01-16	2015-01-15	4	ZLTQ	Zeltiq Aesthetics Inc Stock Options (Right to Buy)	M - Exercise		-16,887	1,193	-93.40
2015-01-16	2015-01-15	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale	X	-17,483	0	-100.00	29.26	-511,490
2015-01-16	2015-01-15	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	M - Exercise		596	17,483	3.53	5.06	3,016	88,464
2015-01-16	2015-01-15	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	M - Exercise		16,887	16,887		6.34	107,064	107,064
2015-01-09	2015-01-08	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		10,000	10,000
2014-12-10	2014-12-09	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-8,778	1,310,650	-0.67	40.11	-352,086	52,570,172
2014-12-10	2014-12-08	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-5,486	1,814,434	-0.30	46.02	-252,466	83,500,253
2014-12-10	2014-12-08	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-83,143	1,819,920	-4.37	45.33	-3,768,872	82,496,974
2014-11-04	2014-11-03	4	ZLTQ	Zeltiq Aesthetics Inc Stock Options (Right to Buy)	M - Exercise		-5,563	3,973	-58.34
2014-11-04	2014-11-03	4	ZLTQ	Zeltiq Aesthetics Inc Stock Options (Right to Buy)	M - Exercise		-11,920	18,080	-39.73
2014-11-04	2014-11-03	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale	X	-17,483	0	-100.00	25.15	-439,629
2014-11-04	2014-11-03	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	M - Exercise		5,563	17,483	46.67	5.06	28,149	88,464
2014-11-04	2014-11-03	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	M - Exercise		11,920	11,920		6.34	75,573	75,573
2014-10-09	2014-10-07	4	CALA	Calithera Biosciences, Inc. SERIES D PREFERRED STOCK	C - Conversion		634,195	0	-100.00
2014-10-09	2014-10-07	4	CALA	Calithera Biosciences, Inc. SERIES C PREFERRED STOCK	C - Conversion		747,540	0	-100.00
2014-10-09	2014-10-07	4	CALA	Calithera Biosciences, Inc. SERIES B PREFERRED STOCK	C - Conversion		419,181	0	-100.00
2014-10-09	2014-10-07	4	CALA	Calithera Biosciences, Inc. SERIES A PREFERRED STOCK	C - Conversion		9,166	0	-100.00
2014-10-09	2014-10-07	4	CALA	Calithera Biosciences, Inc. COMMON STOCK	P - Purchase		300,000	2,110,082	16.57	10.00	3,000,000	21,100,820
2014-10-09	2014-10-07	4	CALA	Calithera Biosciences, Inc. COMMON STOCK	C - Conversion		1,810,082	1,810,082
2014-07-31	2014-07-31	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale		-10,495	0	-100.00	20.09	-210,850
2014-07-31	2014-07-31	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale		-18,662	0	-100.00	20.09	-374,929
2014-06-27	2014-06-26	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale	X	-10,320	1,903,063	-0.54	35.01	-361,303	66,626,236
2014-06-27	2014-06-25	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale	X	-171	1,913,383	-0.01	35.00	-5,985	66,968,405
2014-06-24	2014-06-24	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale	X	-10,402	1,913,554	-0.54	35.03	-364,382	67,031,797
2014-06-24	2014-06-23	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale	X	-13,618	1,923,956	-0.70	35.27	-480,307	67,857,928
2014-06-24	2014-06-20	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale	X	-1,457	1,937,574	-0.08	35.02	-51,024	67,853,841
2014-06-03	2014-05-30	4	ZLTQ	Zeltiq Aesthetics Inc Stock Option (Right to Buy)	A - Award		30,000	30,000
2014-05-06	2014-05-05	4	XLRN	ACCELERON PHARMA INC Common Stock	S - Sale		-215,644	1,939,031	-10.01	42.86	-9,242,502	83,106,869
2014-01-22	2014-01-21	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale		-8,560	10,495	-44.92	22.35	-191,278	234,517
2014-01-22	2014-01-21	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale		-15,220	0	-100.00	22.35	-340,100
2014-01-22	2014-01-17	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale		-2,627	19,055	-12.12	23.50	-61,739	447,829
2014-01-22	2014-01-17	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale		-4,673	15,220	-23.49	23.50	-109,824	357,699
2014-01-22	2014-01-17	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	J - Other		19,893	19,893
2014-01-22	2014-01-17	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	J - Other		-36,210	33,969	-51.60
2014-01-22	2014-01-17	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	J - Other		-75,333	70,671	-51.60
2014-01-22	2014-01-17	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	J - Other		-1,877,270	1,761,086	-51.60
2013-12-09	2013-12-05	4	XLRN	ACCELERON PHARMA INC Option to Purchase Common Stock	A - Award		20,000	20,000
2013-11-18	2013-11-14	4	ZLTQ	Zeltiq Aesthetics Inc Common Stock	S - Sale		-4,025,000	3,876,221	-50.94	12.22	-49,185,500	47,367,421
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Series F Convertible Preferred Stock	C - Conversion		-64,019	0	-100.00
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Series E Convertible Preferred Stock	J - Other		-138,862	0	-100.00
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Series D Convertible Preferred Stock	C - Conversion		-39,172	0	-100.00
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Series C Convertible Preferred Stock	C - Conversion		-293,142	0	-100.00
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Series B Convertible Preferred Stock	C - Conversion		-507,664	0	-100.00
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Series A Convertible Preferred Stock	C - Conversion		-1,376,248	0	-100.00
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Common Stock	C - Conversion		64,019	2,513,783	2.61
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Common Stock	J - Other		223,806	2,449,764	10.05
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Common Stock	C - Conversion		39,172	2,225,958	1.79
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Common Stock	C - Conversion		293,142	2,186,786	15.48
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Common Stock	C - Conversion		507,664	1,893,644	36.63
2013-09-26	2013-09-24	4	XLRN	ACCELERON PHARMA INC Common Stock	C - Conversion		1,376,248	1,385,980	14,141.47
2013-09-18		3	XLRN	ACCELERON PHARMA INC Common Stock				9,732
2013-06-20	2013-06-19	4	ZLTQ	Zeltiq Aesthetics Inc Stock Options (Right to Buy)	A - Award		30,000	30,000
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series D Preferred Stock	C - Conversion		-512	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series D Preferred Stock	C - Conversion		-85,939	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series D Preferred Stock	C - Conversion		-1,657	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series D Preferred Stock	C - Conversion		-3,448	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion		-2,569	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion		-431,173	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion		-8,316	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion		-17,302	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-5,551	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-931,468	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-17,966	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-37,379	0	-100.00
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Common Stock	C - Conversion		8,632	8,632
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Common Stock	C - Conversion		1,448,580	1,448,580
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Common Stock	C - Conversion		27,939	27,939
2013-05-30	2013-05-28	4	PTLA	PORTOLA PHARMACEUTICALS INC Common Stock	C - Conversion		58,129	58,129
2012-06-18	2012-06-14	4	ZLTQ	Zeltiq Aesthetics Inc Stock Option (Right to Buy)	A - Award		9,536	9,536
2011-10-18		3	ZLTQ	Zeltiq Aesthetics Inc Common Stock				7,901,221

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）